ArticleHaematologica2025

Successful treatment of refractory cold agglutinin syndrome using fixed-duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge.

Brad Rybinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.